Dialysis-related amyloidosis during peritoneal dialysis.
Patients treated with long-term hemodialysis may develop carpal tunnel syndrome, cystic bone lesions, and/or an arthropathy. This syndrome has been called hemodialysis-related amyloidosis (HRA) and appears to be the result of the accumulation of polymerized Beta-2 microglobulin (B2M). The risk to patients treated with peritoneal dialysis is unknown. Diphosphonate scans have been advocated as a useful noninvasive test for HRA. The authors report a well-documented case of HRA established during hemodialysis and progressing during peritoneal dialysis. In addition, this patient's HRA was not identified by a diphosphonate scan. This is the second well-documented case of HRA associated with peritoneal dialysis.
Brown
E
E
Division of Nephrology, Yale University School of Medicine, New Haven, Connecticut 06510.
Soldano
L
L
Hendler
E
E
D000368:Aged; D000686:Amyloidosis / Q000000981:diagnostic imaging / Q000209:etiology*; D006801:Humans; D008297:Male; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D011859:Radiography; D006435:Renal Dialysis / Q000009:adverse effects*